Tata Elxsi, a global leader in design and technology services, has partnered with Terumo Corporation, a leading medical innovation company, to inaugurate the ‘Terumo–Tata Elxsi Offshore Development Center’. This dedicated facility will support the development of Terumo’s cardiac and vascular solutions while strengthening engineering and innovation capabilities across global markets.
Strengthening Innovation in Cardiac and Vascular Technologies
The new center will focus on enhancing the design, development, and lifecycle management of cardiac and vascular devices. As a result, it will improve product reliability and performance while ensuring compliance with international standards and evolving healthcare needs.
Moreover, the collaboration aims to expand the global availability of advanced medical technologies and deliver solutions that align with both provider and patient expectations.
Multidisciplinary Expertise for Faster Development
As per the press release, the center brings together multidisciplinary teams that combine Tata Elxsi’s strengths in design, engineering, verification, regulatory compliance, and localisation. In addition, the integration of AI and GenAI capabilities into software engineering will further accelerate innovation.
Consequently, this approach enables faster product development, efficient regional adaptation, and the creation of patient-centric medical devices with enhanced cost efficiency and differentiation.
Leadership Perspective on Strategic Collaboration
Fumihisa Hirose, President of the Cardiac & Vascular Company at Terumo Corporation, emphasized that the Offshore Development Center will accelerate innovation and enable the delivery of high-quality medical technologies across global markets. He also highlighted that Tata Elxsi’s integrated capabilities will help advance the company’s product roadmap while maintaining high standards of safety and compliance.
Long-Term Partnership Driving Next-Gen Solutions
Sreevatsa Sahasranaman, Senior Vice President and Head – Healthcare & Life Sciences at Tata Elxsi, described the initiative as a long-term strategic partnership. He noted that the collaboration combines cross-functional expertise with advanced AI- and GenAI-powered technologies to drive innovation and cost efficiency across Terumo’s cardiovascular portfolio.
Enabling Future-Ready Healthcare Solutions
Ultimately, this Offshore Development Center will play a key role in developing next-generation medical technologies. By leveraging advanced engineering, regulatory expertise, and digital innovation, the partnership aims to bring cutting-edge cardiac and vascular solutions to both global and emerging markets.